TEL AVIV, July 2 /PRNewswire/ -- RCS Limited (http://www.rcs.com), the world's largest international trader of cellular phones, today announced a fraud warning to operators, distributors and wholesalers of cellular phones. Over the last quarter, RCS' network of cellular phone traders, spanning 128 countries, has reported an increase in fraudulent trading on the open market.

Among the more common cases of fraud reported to RCS are a fictitious sales representative posing as an employee of an established company. In this example,

NEW BRUNSWICK, New Jersey and DUBLIN, July 2 /PRNewswire/ --

- First-in-Class Alzheimer's Treatments Expand Existing JJ Neuroscience Pipeline

- Johnson Johnson Equity Investment Provides Financial Flexibility for Elan

Johnson Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) today announced a definitive agreement whereby Johnson Johnson will acquire substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program (AIP Program), through a newly formed company. In addition, Johnson Johnson, through its affiliate, will invest $1 billion in Elan in exchange for newly issued American Depositary Receipts (ADRs) of Elan which will represent 18.4% of Elan's outstanding ordinary shares.

True Math Genius
This trick will bring a smile to the face of even the most hardened math geek. First, lay matches on a table to form the equation I + II + III = IIII (crossed matches make the plus signs and parallel matches make the equals sign). Challenge your opponent to make this statement true by moving only one match and without messing with the sum after the equals sign. The trick is to pick up one match from the II, and lay it across the middle match in the III, making the full equation read:
I + I + I + I =IIII.

Two Glasses II

CAMBRIDGE, England, June 2 /PRNewswire/ -- AVEVA (LSE:AVV) announced today that it has made further enhancements to its AVEVA Marine portfolio.

With a main focus on interoperability, this new release of the AVEVA Marine portfolio now offers AVEVA's marine customers extended possibilities for data exchange between various sources.

AVEVA Marine users will now be able to integrate PIDs and schematic diagrams coming from various systems, including the AVEVA PID solution.

This brings a real benefit to customers as they are now free to select their PID system from various sources and even to integrate PIDs from other authoring systems into a complete model of their project.

HSINCHU, Taiwan, July 2 /PRNewswire/ --

- Provides greater design flexibility and higher performance

Taiwan Semiconductor Manufacturing Company, Ltd. (TWSE: 2330, NYSE: TSM) today announced the foundry segment's first functional 65-nanometer (nm) multi-time programmable (MTP) non-volatile memory (NVM) process technology. The technology incorporates process-qualified MTP IP blocks jointly developed with Virage Logic. The new technology is the first 2.5 volt MTP process, breaking the heretofore 3.3 volt baseline barrier. It eliminates the need for an external EEPROM currently in many systems applications, thereby reducing power, area and costs while increasing data security.

LONDON, July 2 /PRNewswire/ -- Iran's oil production and exploitation of huge gas reserves needs foreign investment. But high profile arrests in the months ahead will deter investors. Nevertheless, Iran has shown a remarkable capability to tough out the worst of economic conditions and international disapproval, according to David Butter of the Economist Intelligence Unit.

The video programme is available now on http://w3.cantos.com/economist.

It's free to view. All you need to do is register at http://www.cantos.com. Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email enquiries@cantos.com or phone +44(0)207-936-1333.

LONDON, July 2 /PRNewswire/ --

During times of financial crisis and economic downturn, logistic and transportation companies as well as commercial fleets in other industries suffer from increasing fuel costs and shrinking revenues. A large number of these companies must struggle to survive. In this context, an investment in commercial vehicle telematics truly pays off as it helps fleets boost their productivity while decreasing costs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

LONDON, July 2 /PRNewswire/ -- Global leaders in augmented reality, Total Immersion, are taking the marketing world by storm after kick-starting their UK operation with a series of groundbreaking launch campaigns.

The French software company, which specialises in blurring the real and virtual worlds to create new consumer experiences, has been working with several big brand names since opening in the UK three months ago and has just unveiled its latest campaign to promote the launch of Transformers: Revenge of the Fallen.

MOSCOW, July 2 /PRNewswire/ -- Company TTK today announced the preliminary results of its new development strategy for 2008-2015, showing significant growth in new market segments within this new framework. The strategy will see TTK develop retail and broadband Internet access, local and long distance call telephony, as well as other retail telecommunication services across Russian regions and aims to increase TTK's regional fixed communications market share to 17 percent, or more than 2 million households, by 2015.

PARIS, July 2 /PRNewswire/ --

- Multaq(R) Approved to Reduce the Risk of Cardiovascular Hospitalization in Patients With Atrial Fibrillation or Atrial Flutter

- U.S Commercial Launch Planned for the Summer of 2009

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve current management of their disease. Multaq(R) is the first drug approved in the United States that has shown a clinical benefit to reduce cardiovascular hospitalization in patients with AF/AFL.